The 3 Best Yielding Top Stocks From Ken Fisher’s Q3/2012 Fund Portfolio

DIV: Global X Super Dividend ETF logo
DIV
Global X Super Dividend ETF

Submitted by Dividend Yield as part of our contributors program.

Originally published at “long-term-investments.blogspot.com“. Kenneth Fisher is an American businessman, founder and chairman as well as CEO of Fisher Investments, a money management firm headquartered in California. Fisher writes the monthly “Portfolio Strategy” column in Forbes magazine. Ken Fisher is one of the richest Americans and part of the Forbes 400 list of world billionaires. Funds run by Ken Fisher at Fisher Asset Management were valued at USD 34.91 billion.
Here is a top 30 list of his investment positions as of September 30, 2012. During the quarter Q3/2012, Ken Fisher had 458 total positions.

Top New Buys: CMCSA, PBR, TM, RY, NVS, VOD, CHL, NTGR, SAM, WRC

Relevant Articles
  1. Beating S&P500 BY 11% YTD, What To Expect From Travelers Stock?
  2. Up 50% Over The Last 12 Months, Is Hyatt Stock Still Attractive?
  3. Capital One Stock Gained 44% In The Last 6 Months, What’s Next?
  4. Up 8% Year To Date As 5G Gains Traction, What’s Next For Verizon Stock?
  5. Up 32% In The Last 12 Months, Where Is BNY Mellon Stock Headed?
  6. Rallying 30% YTD, What’s Spurring The Rally In Applied Materials’ Stock?

Here are the 3 best yielding of Ken Fisher’s top dividend stocks:

GlaxoSmithKline (GSK) has a market capitalization of $107.56 billion. The company employs 97,389 people, generates revenue of $44.150 billion and has a net income of $8.798 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $14.844 billion. The EBITDA margin is 33.62 percent (the operating margin is 28.50 percent and the net profit margin 19.93 percent).

Financial Analysis: The total debt represents 36.27 percent of the company’s assets and the total debt in relation to the equity amounts to 185.52 percent. Due to the financial situation, a return on equity of 62.19 percent was realized. Twelve trailing months earnings per share reached a value of $3.20. Last fiscal year, the company paid $2.26 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 13.66, the P/S ratio is 2.42 and the P/B ratio is finally 8.48. The dividend yield amounts to 5.31 percent and the beta ratio has a value of 0.65.

Pfizer (PFE) has a market capitalization of $184.65 billion. The company employs 103,700 people, generates revenue of $67.425 billion and has a net income of $8.739 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $23.011 billion. The EBITDA margin is 34.13 percent (the operating margin is 18.93 percent and the net profit margin 12.96 percent).

Financial Analysis: The total debt represents 20.72 percent of the company’s assets and the total debt in relation to the equity amounts to 47.39 percent. Due to the financial situation, a return on equity of 10.24 percent was realized. Twelve trailing months earnings per share reached a value of $1.25. Last fiscal year, the company paid $0.80 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 20.03, the P/S ratio is 2.74 and the P/B ratio is finally 2.31. The dividend yield amounts to 3.83 percent and the beta ratio has a value of 0.70.

General Electric (GE) has a market capitalization of $218.32 billion. The company employs 301,000 people, generates revenue of $147.300 billion and has a net income of $14.366 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $31.015 billion. The EBITDA margin is 21.06 percent (the operating margin is 13.64 percent and the net profit margin 9.75 percent).

Financial Analysis: The total debt represents 63.22 percent of the company’s assets and the total debt in relation to the equity amounts to 389.43 percent. Due to the financial situation, a return on equity of 11.06 percent was realized. Twelve trailing months earnings per share reached a value of $1.35. Last fiscal year, the company paid $0.61 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 15.45, the P/S ratio is 1.48 and the P/B ratio is finally 1.89. The dividend yield amounts to 3.65 percent and the beta ratio has a value of 1.61.

Take a closer look at all top portfolio positions of Ken Fisher. The average P/E ratio amounts to 19.09. The dividend yield has a value of 2.71 percent. Price to book ratio is 4.03 and price to sales ratio 3.18.

Monthly Yield Fact Book | Yields Dividend Champions | Yields Dividend Contenders | Yields Dividend Challengers | High-Yield Large Cap | +10% Yielding Stocks |

(Subscribe my Blog via RSS Feed or E-Mail. Alternative, you can follow me on Facebook or Twitter)